PH10345A - N-methyl-d-glucamine of 2(2'-methyl-3'-trifluoro-methylanilino nicotinic acid,pharmaceutical composition containing the same and method of use thereof - Google Patents

N-methyl-d-glucamine of 2(2'-methyl-3'-trifluoro-methylanilino nicotinic acid,pharmaceutical composition containing the same and method of use thereof

Info

Publication number
PH10345A
PH10345A PH15663*A PH15663A PH10345A PH 10345 A PH10345 A PH 10345A PH 15663 A PH15663 A PH 15663A PH 10345 A PH10345 A PH 10345A
Authority
PH
Philippines
Prior art keywords
methyl
methylanilino
glucamine
trifluoro
pharmaceutical composition
Prior art date
Application number
PH15663*A
Other languages
English (en)
Inventor
M Sherlock
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of PH10345A publication Critical patent/PH10345A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
PH15663*A 1973-03-28 1974-03-26 N-methyl-d-glucamine of 2(2'-methyl-3'-trifluoro-methylanilino nicotinic acid,pharmaceutical composition containing the same and method of use thereof PH10345A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00345608A US3839344A (en) 1973-03-28 1973-03-28 N-methyl d-glucamine salt of 2(2'-methyl-3'-trifluoromethylanilino)nicotinic acid

Publications (1)

Publication Number Publication Date
PH10345A true PH10345A (en) 1976-12-09

Family

ID=23355713

Family Applications (1)

Application Number Title Priority Date Filing Date
PH15663*A PH10345A (en) 1973-03-28 1974-03-26 N-methyl-d-glucamine of 2(2'-methyl-3'-trifluoro-methylanilino nicotinic acid,pharmaceutical composition containing the same and method of use thereof

Country Status (18)

Country Link
US (1) US3839344A (da)
JP (2) JPS596853B2 (da)
AU (1) AU474219B2 (da)
BE (1) BE812772A (da)
CA (1) CA969549A (da)
CH (1) CH589059A5 (da)
CY (1) CY969A (da)
DE (1) DE2414273C3 (da)
DK (1) DK132322C (da)
ES (1) ES424609A1 (da)
FR (1) FR2223016B1 (da)
GB (1) GB1406594A (da)
HK (1) HK62178A (da)
KE (1) KE2892A (da)
NL (1) NL177688C (da)
PH (1) PH10345A (da)
SE (1) SE389338B (da)
ZA (1) ZA741906B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205073A (en) * 1975-04-30 1980-05-27 Schering Corporation Anti-diarrheal anilino nicotinic acids and method of using same
DE2750170A1 (de) * 1976-11-12 1978-05-18 Ciba Geigy Ag 2-methyl-4-trifluormethyl-anilin, ein verfahren zu seiner herstellung und seine verwendung
JPS5524101A (en) * 1978-08-08 1980-02-21 Mitsubishi Yuka Yakuhin Kk New quinolopyran derivative and antiallergic remedy for asthma
US4255581A (en) * 1979-08-13 1981-03-10 Laboratories Bago, S.A. Process for the preparation of alkyl and aryl esters of 3'-substituted and 2', 3'-disubstituted 2-anilino-3-pyridinecarboxylic acids
US4322424A (en) * 1980-01-24 1982-03-30 Bristol-Myers Company Crystalline glucoconate salt of m-AMSA and compositions containing same
FR2537579B1 (fr) * 1982-12-10 1985-07-26 Bago Sa Labor Procede de preparation d'esters alkyliques et aryliques d'acides 2-anilino-3-pyridine-carboxyliques 3'-substitues et 2', 3'-disubstitues
JPS6016567U (ja) * 1983-04-30 1985-02-04 京セラ株式会社 太陽電池装置
JPS59171353U (ja) * 1983-07-25 1984-11-16 京セラ株式会社 太陽電池装置
JPS62198583U (da) * 1986-06-06 1987-12-17
AU659106B2 (en) * 1990-11-06 1995-05-11 Fgn, Inc. Method for treating colonic polyps by the use of esters and amides of substituted phenyl and pyridyl amino carboxylates
NZ246433A (en) * 1991-12-20 1995-10-26 Schering Corp Process for the preparation of 2-methyl-3-trifluoromethyl-aniline and a pivalanilide intermediate thereof
JPH06163964A (ja) * 1992-07-21 1994-06-10 Osaka Shosen Mitsui Senpaku Kk 飛行船用太陽電池装着機構
US5248781A (en) * 1992-09-21 1993-09-28 The Trustees Of Princeton University Preparation of substituted anilino-nicotinic acid derivatives
JP2698306B2 (ja) * 1993-01-18 1998-01-19 セントラル硝子株式会社 2−メチル−3−アミノベンゾトリフロライドの製造方法
US20050239748A1 (en) * 2004-03-17 2005-10-27 Panacos Pharmaceuticals, Inc. Pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl) betulinic acid
EP2228367A1 (en) * 2009-03-13 2010-09-15 Almirall, S.A. Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337570A (en) * 1965-10-23 1967-08-22 Schering Corp Substituted nicotinic acids and method for the manufacture thereof

Also Published As

Publication number Publication date
CH589059A5 (da) 1977-06-30
NL177688B (nl) 1985-06-03
AU6708574A (en) 1975-09-25
JPS5939405B2 (ja) 1984-09-22
DE2414273A1 (de) 1974-10-17
DK132322C (da) 1976-05-03
CA969549A (en) 1975-06-17
NL7403989A (da) 1974-10-01
HK62178A (en) 1978-11-03
AU474219B2 (en) 1976-07-15
DK132322B (da) 1975-11-24
ZA741906B (en) 1975-03-26
CY969A (en) 1978-12-22
KE2892A (en) 1978-10-27
JPS5984822A (ja) 1984-05-16
JPS49125513A (da) 1974-12-02
FR2223016A1 (da) 1974-10-25
SE389338B (sv) 1976-11-01
BE812772A (fr) 1974-09-25
NL177688C (nl) 1985-11-01
US3839344A (en) 1974-10-01
ES424609A1 (es) 1976-06-01
GB1406594A (en) 1975-09-17
DE2414273B2 (de) 1980-09-11
FR2223016B1 (da) 1977-05-06
JPS596853B2 (ja) 1984-02-15
DE2414273C3 (de) 1981-11-19

Similar Documents

Publication Publication Date Title
IL49095A (en) 1,4dihydropyridine-3,5-di-carboxylic acid aralkyl esters their preparation and pharmaceutical compositions containing them
PH11112A (en) Pyridoindoles,composition containing them and their method of use
PH10345A (en) N-methyl-d-glucamine of 2(2'-methyl-3'-trifluoro-methylanilino nicotinic acid,pharmaceutical composition containing the same and method of use thereof
IL49411A0 (en) Phenylalkane-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA777532B (en) 1,4-dihydropyridine compounds,process for preparation thereof and pharmaceutical composition of the same
IL46966A0 (en) 1,1-diaryl-1-oxadiazolyl-alkylamines,their preparation and pharmaceutical compositions containing them
IL49424A0 (en) 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them
IL51309A0 (en) New 1,2-benzisothiazolin-3-ones,their preparation and pharmaceutical compositions containing them
IL50507A0 (en) Phenoxyalkylcarboxylic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL50736A0 (en) Phenoxyalkylcarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL50091A0 (en) New oxazolidinones,their production and pharmaceutical compositions containing them
IL49352A0 (en) New carboxylic acid amides,their preparation and pharmaceutical compositions containing them
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
PH14398A (en) Pharmaceutical compounds,compositions containing same and method of use
IL46543A0 (en) New phenoxyalkyl-carboxylic acid derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IL50797A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
IL54729A (en) 6 beta-(azaoligocycloalkyl-methyleneamino)-penicillanic acids,their preparation and pharmaceutical compositions containing them
IL46476A0 (en) 2-substituted 4,5-diphenylthiazoles,their preparation and pharmaceutical compositions containing them
GR60551B (en) Pharmaceutical compositions containing heterocolloidal debrycin and process for the preparation thereof
IL49099A0 (en) New xanthene-9-carboxylates,their preparation and pharmaceutical compositions containing them
PH13873A (en) Substituted thenoylacetic acid and esters,their pharmaceutical composition and method of use
IL53552A (en) 1-piperazinopropanol esters,their preparation and pharmaceutical compositions containing them
IL47761A0 (en) 19,20-bis-nor-prostanoic acids,their preparation and pharmaceutical compositions containing them
IL50554A (en) 2,9-dioxatricyclodecanes,their preparation and pharmaceutical compositions containing them
IL46409A (en) 7,8-dihalo-1,2,3,4-tetrahydro-isoquinolines their preparation and pharmaceutical compositions containing them